253345-80-1 Usage
Uses
Used in Cardiovascular Applications:
2-HYDROXYMETHYL-3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDINE HCL is used as an antiplatelet and antithrombotic agent for the treatment and prevention of cardiovascular diseases. It is particularly effective in managing conditions such as acute myocardial infarction and ischemic stroke, where the risk of blood clot formation is heightened.
Used in Anti-Inflammatory Applications:
In the medical field, 2-HYDROXYMETHYL-3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDINE HCL is utilized as an anti-inflammatory agent, leveraging its ability to reduce inflammation associated with various conditions. Its antipyretic and analgesic properties further contribute to its efficacy in alleviating fever and pain, respectively.
Used in Pharmaceutical Industry:
2-HYDROXYMETHYL-3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDINE HCL is used as a key ingredient in the development of pharmaceutical formulations aimed at preventing and treating blood clot-related disorders and inflammatory conditions. Its multifaceted pharmacological profile makes it a valuable asset in the creation of versatile medications for a broad spectrum of health issues.
Check Digit Verification of cas no
The CAS Registry Mumber 253345-80-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,3,3,4 and 5 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 253345-80:
(8*2)+(7*5)+(6*3)+(5*3)+(4*4)+(3*5)+(2*8)+(1*0)=131
131 % 10 = 1
So 253345-80-1 is a valid CAS Registry Number.
253345-80-1Relevant academic research and scientific papers
Diversified synthesis of novel quinoline and dibenzo thiazepine derivatives using known active intermediates
Sharada,Satyanarayana Reddy,Sammaiah,Sumalatha
, p. 7959 - 7966 (2013/09/23)
The novel drug development to control resisting infections in conventional drug therapy is a need of today. Few antiulcer relative derivatives developed by approaching convergent synthesis. The derivatives synthesized successfully are dibenzo thiazepine-pyridine (SLN11-SLN15) and benzimidazole-hydroquinoline based derivatives (SLN16-SLN20). It involved the coupling through microwave, sonication and conventional techniques at final step. The efficient technology identified as sonication technique basically time and yield. The reported compounds were structural characterized by elemental analysis and spectral studies such as 1H, 13C NMR and MS.
